MedTrace Logo

Conditions Associated With Poorly Controlled Diabetes in Patients With Type 2 Diabetes and HbA1c Changes With Therapy

NCT05394571 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2022-08-03

No results posted yet for this study

Summary

In Turkey, only 55% of patients with type 2 diabetes have been diagnosed, and 91% of these patients have been receiving treatment. The rate of patients reaching the treatment target is 50%. The pandemic has also affected diabetic patients. We aimed to determine the characteristics of patients with type 2 diabetes (HbA1c \>=10) with poor metabolic control and to evaluate the extent to which metabolic control can be achieved in 3 months.

Conditions

Sponsors & Collaborators

  • Goztepe Training and Research Hospital

    lead OTHER

Principal Investigators

  • Ayse N Erbakan, MD · Istanbul Goztepe Prof. Dr. Suleyman Yalcin City Hospital

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-15
Primary Completion
2022-07-15
Completion
2022-07-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05394571 on ClinicalTrials.gov